David Geffen

Ben-Gurion University of the Negev — Israel

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index2.0kcitations130works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(25), HER2/EGFR in Cancer Research(14), Cancer Treatment and Pharmacology(14), Advanced Breast Cancer Therapies(11), Lymphoma Diagnosis and Treatment(9)

Publications127 total

62370 Efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis affecting the nails: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b trial
Journal of the American Academy of Dermatology·2025
Prophylactic Irradiation of the Contralateral Breast for <i>BRCA</i> Carriers With Early Breast Cancer
JAMA Oncology·2025
Stage I Breast Cancer in the Modern Era: A Retrospective Cohort Study of 328 Patients Diagnosed from 2002 to 2006 with a 14-Year Median Follow-Up
Oncology·2024
Stage I (T1N0M0) breast cancer with a median follow-up of 14 years: A retrospective cohort study of 328 consecutive patients and the prognostic value of tumor size, grade, and subtype
Research Square (Research Square)·2023Open Access
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years
Breast Cancer Research and Treatment·2022· 4 cited
Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study
npj Breast Cancer·2022· 16 citedOpen Access
Neoadjuvant Therapy with Doxorubicin-Cyclophosphamide Followed by Weekly Paclitaxel in Early Breast Cancer: A Retrospective Analysis of 200 Consecutive Patients Treated in A Single Center with A Median Follow-Up of 9.5 Years.
2022· 1 citedOpen Access
Error in Results, Figures, and Tables
JAMA Psychiatry·2021Open Access
Omission of Prophylactic Cranial Irradiation in the Management of Limited-Stage Small-Cell Lung Cancer: Is that Ready for Prime-Time? An International Survey
Clinics in Oncology·2021Open Access
Direct comparison shows that mRNA-based diagnostics incorporate information which cannot be learned directly from genomic mutations
BMC Bioinformatics·2020· 8 citedOpen Access
Does Assessment Method Matter in Detecting Mental Health Distress among Ashkenazi and Mizrahi Israeli Women with Breast Cancer?
Health & Social Work·2020· 1 cited
Additional file 1 of Direct comparison shows that mRNA-based diagnostics incorporate information which cannot be learned directly from genomic mutations
Figshare·2020Open Access
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy
npj Breast Cancer·2019· 27 citedOpen Access
The Prognostic Value of the Pretreatment Neutrophil/Lymphocyte Ratio in Patients with Glioblastoma Multiforme Brain Tumors: A Retrospective Cohort Study of Patients Treated with Combined Modality Surgery, Radiation Therapy, and Temozolomide Chemotherapy
Oncology·2019· 21 cited
Prophylactic irradiation to the contralateral breast for BRCA mutation carriers with early-stage breast cancer
Annals of Oncology·2018· 54 citedOpen Access
Phase II national clinical trial of prophylactic irradiation to the contralateral breast for BRCA mutation carriers treated for early breast cancer (EBC).
Journal of Clinical Oncology·2018· 3 cited
Should decisions on adding adjuvant chemotherapy in early-stage ER-positive breast cancer be based on gene expression testing or clinicopathologic factors or both?
Annals of Oncology·2018· 6 citedOpen Access
Clinical outcomes in ER+ HER2 -node-positive breast cancer patients who were treated according to the Recurrence Score results: evidence from a large prospectively designed registry
npj Breast Cancer·2017· 85 citedOpen Access
Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry
npj Breast Cancer·2017· 68 citedOpen Access
Treatments/clinical outcomes in ER+ HER2-negative breast cancer (BC) where treatment decisions were recurrence score (RS)-guided: Analysis by histologic subtype.
Journal of Clinical Oncology·2017
page 1 of 7Next →

Frequent Co-authors

Samuel Ariad(14), Margarita Tokar(7), Michael Koretz(7), Salomon M. Stemmer(6), Daniel Benharroch(6), Georgeta Fried(5), Victor Novack(5), Shulamith Rizel(4), Lior Soussan‐Gutman(4), Ora Rosengarten(4), Noa Ben-Baruch(4), Bella Kaufman(4), Merav Fraenkel(4), Ethel S. Siris(4), Larry Norton(4), Tali Shafat(4), Bella Nisenbaum(3), Avital Bareket‐Samish(3), Christer Svedman(3), Steven Shak(3)